SHAPERON INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,105 KRW | +9.86% |
|
+5.30% | -44.02% |
| Mar. 18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
| 2022 | Shaperon Inc. has completed an IPO in the amount of KRW 13.735 billion. | CI |
- Stock Market
- Equities
- A378800 Stock
- News Shaperon Inc.
- Press Releases
